182 related articles for article (PubMed ID: 10874883)
41. Comparison of alpha beta and gamma delta expressing CD3+ acute lymphoblastic leukemias.
Macintyre EA; Salloum E; Sigaux F
Nouv Rev Fr Hematol (1978); 1990; 32(1):95-9. PubMed ID: 2140885
[TBL] [Abstract][Full Text] [Related]
42. Automatic lineage assignment of acute leukemias by flow cytometry.
Verwer BJ; Terstappen LW
Cytometry; 1993 Nov; 14(8):862-75. PubMed ID: 7507022
[TBL] [Abstract][Full Text] [Related]
43. Adult precursor T-lymphoblastic leukemia/lymphoma with myeloid-associated antigen expression is associated with a lower complete remission rate following induction chemotherapy.
Al Khabori M; Samiee S; Fung S; Xu W; Brandwein J; Patterson B; Brien W; Chang H
Acta Haematol; 2008; 120(1):5-10. PubMed ID: 18635939
[TBL] [Abstract][Full Text] [Related]
44. Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry.
Gelain ME; Mazzilli M; Riondato F; Marconato L; Comazzi S
Vet Immunol Immunopathol; 2008 Feb; 121(3-4):179-88. PubMed ID: 17981339
[TBL] [Abstract][Full Text] [Related]
45. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
46. Lymphomatoid keratosis: an epidermotropic type of cutaneous lymphoid hyperplasia: clinicopathological, immunohistochemical, and molecular biological study of 6 cases.
Arai E; Shimizu M; Tsuchida T; Izaki S; Ogawa F; Hirose T
Arch Dermatol; 2007 Jan; 143(1):53-9. PubMed ID: 17224542
[TBL] [Abstract][Full Text] [Related]
47. Refractory T cell acute lymphoblastic leukemia with unusual karyotype and interesting immunophenotype.
Anreder MB; Mitruka BM; Gill J; Varela M; Rozans MK; Krause JR
J La State Med Soc; 1996 Dec; 148(12):521-4. PubMed ID: 8990795
[TBL] [Abstract][Full Text] [Related]
48. Myeloid surface antigen-positive acute lymphoblastic leukemia (My+ ALL): immunophenotypic, ultrastructural, cytogenetic, and molecular characteristics.
Childs CC; Hirsch-Ginsberg C; Walters RS; Andersson BS; Reuben J; Trujillo JM; Cork A; Stass SA; Freireich EJ; Zipf TF
Leukemia; 1989 Nov; 3(11):777-83. PubMed ID: 2811478
[TBL] [Abstract][Full Text] [Related]
49. CD20+ T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature.
Rahemtullah A; Longtine JA; Harris NL; Dorn M; Zembowicz A; Quintanilla-Fend L; Preffer FI; Ferry JA
Am J Surg Pathol; 2008 Nov; 32(11):1593-607. PubMed ID: 18753947
[TBL] [Abstract][Full Text] [Related]
50. Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience.
Goldberg JM; Silverman LB; Levy DE; Dalton VK; Gelber RD; Lehmann L; Cohen HJ; Sallan SE; Asselin BL
J Clin Oncol; 2003 Oct; 21(19):3616-22. PubMed ID: 14512392
[TBL] [Abstract][Full Text] [Related]
51. Primary, solitary, adult T-cell leukemia / lymphoma of the descending colon.
Hidaka H; Hotokezaka M; Iwamura T; Moriguchi S; Marutsuka K; Toyama T; Chijiiwa K
J Gastroenterol; 2004 Aug; 39(8):788-92. PubMed ID: 15338374
[TBL] [Abstract][Full Text] [Related]
52. Shifts in expression of immunological cell markers in relapsed acute leukemia.
Tomová A; Babusíková O
Neoplasma; 2001; 48(3):164-8. PubMed ID: 11583283
[TBL] [Abstract][Full Text] [Related]
53. Minimal residual disease monitoring in adult T-cell acute lymphoblastic leukemia: a molecular based approach using T-cell receptor G and D gene rearrangements.
Gameiro P; Mortuza FY; Hoffbrand AV; Foroni L
Haematologica; 2002 Nov; 87(11):1126-34. PubMed ID: 12414341
[TBL] [Abstract][Full Text] [Related]
54. Precursor T-cell acute lymphoblastic leukemia in adults: age-related immunophenotypic, cytogenetic, and molecular subsets.
Onciu M; Lai R; Vega F; Bueso-Ramos C; Medeiros LJ
Am J Clin Pathol; 2002 Feb; 117(2):252-8. PubMed ID: 11863221
[TBL] [Abstract][Full Text] [Related]
55. CD3-negative, CD20-positive T-cell prolymphocytic leukemia: case report and review of the literature.
Tamayose K; Sato N; Ando J; Sugimoto K; Oshimi K
Am J Hematol; 2002 Dec; 71(4):331-5. PubMed ID: 12447967
[TBL] [Abstract][Full Text] [Related]
56. Leu-9 (CD 7) positivity in acute leukemias: a marker of T-cell lineage?
Ben-Ezra J; Winberg CD; Wu A; Rappaport H
Hematol Pathol; 1987; 1(3):147-56. PubMed ID: 2472373
[TBL] [Abstract][Full Text] [Related]
57. [Conversion of acute leukemia from a T-lymphoid to a myeloid phenotype].
Sugita K; Nakazawa S; Saito M; Gonda T; Kusumoto Y; Aya M; Osano M; Shimizu M; Okazaki T; Inaba T
Rinsho Ketsueki; 1989 Dec; 30(12):2163-8. PubMed ID: 2621798
[TBL] [Abstract][Full Text] [Related]
58. Optimizing antibody panels for efficient and cost-effective flow cytometric diagnosis of acute leukemia.
Haycocks NG; Lawrence L; Cain JW; Zhao XF
Cytometry B Clin Cytom; 2011; 80(4):221-9. PubMed ID: 21298777
[TBL] [Abstract][Full Text] [Related]
59. Aberrant markers expression in T- and B-lymphoid and myeloid leukemia cells of different differentiation stages.
Babusíková O; Koníková E; Kusenda J; Koubek K
Neoplasma; 1999; 46(5):277-82. PubMed ID: 10665842
[TBL] [Abstract][Full Text] [Related]
60. [Detection of cytoplasmic antigens by flow cytometry and its implication for leukemia immunophenotyping].
Liu YR; Yu H; Chang Y; Chen SS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):17-21. PubMed ID: 12513830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
